Cargando…
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions
BACKGROUND: Post-colonoscopy colorectal cancer (CRC) rates for patients with inflammatory bowel disease (IBD) are unacceptably high. During colonoscopy, an intravenous fluorescent anti-c-MET probe may improve endoscopic detection of lesions. However, c-MET expression in IBD lesions is poorly defined...
Autores principales: | Halliday, Grant, Porter, Ross J, Black, Catherine J, Arends, Mark J, Din, Shahida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099184/ https://www.ncbi.nlm.nih.gov/pubmed/35645542 http://dx.doi.org/10.3748/wjg.v28.i13.1338 |
Ejemplares similares
-
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines
por: Porter, Ross J, et al.
Publicado: (2021) -
QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray
por: Porter, Ross J., et al.
Publicado: (2023) -
Diabetes exacerbates inflammatory bowel disease in mice with diet-induced obesity
por: Francis, Kendra L, et al.
Publicado: (2023) -
Expression of Interleukin-26 is upregulated in inflammatory bowel disease
por: Fujii, Makoto, et al.
Publicado: (2017) -
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease
por: Di Silvestre, Alessia, et al.
Publicado: (2019)